Financing led by Piper Sandler Merchant Banking, with participation from new investors Johnson & Johnson Innovation – JJDC, Inc., Johnson & Johnson's corporate venture capital arm, and Medtronic Participation by existing investors, including Bain Capital Life Sciences and Perceptive...
Hence then, the article about cerevasc inc announces over subscribed 85 million series c financing to advance its novel eshunt system for the treatment of normal pressure hydrocephalus was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus )
Also on site :
- Sweet Magnolias Stars And Creator Say Goodbye To Canceled Netflix Drama: 'I Hope Serenity Will Always Have A Place In Your Heart'
- 01F Group Announces Investment in DANA, Indonesia's Leading Digital Financial Company, Reinforcing Long-Term Confidence in Asia's Fintech Opportunity
- ‘A huge problem’: Trump has traded more stocks than all of Congress combined. A Bush-era ethics lawyer explains why you should worry